RAT INTESTINAL EPITHELIAL-CELLS PRESENT MAJOR HISTOCOMPATIBILITY COMPLEX ALLOPEPTIDES TO PRIMED T-CELLS

被引:34
作者
BRANDEIS, JM [1 ]
SAYEGH, MH [1 ]
GALLON, L [1 ]
BLUMBERG, RS [1 ]
CARPENTER, CB [1 ]
机构
[1] HARVARD UNIV,BRIGHAM & WOMENS HOSP,SCH MED,IMMUNOGENET & TRANSPLANTAT LAB,BOSTON,MA 02115
关键词
D O I
10.1016/0016-5085(94)90560-6
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background/Aims: Intestinal epithelial cells present protein antigens to primed T cells in vitro. The aim of this study was to investigate whether intestinal epithelial cells present peptide antigens in vitro and in vivo after oral administration. Methods: Small intestinal epithelial cells from naive LEW (RT1') rats pulsed in vitro with a synthetic immunogenic major histocompatibility complex allopeptide, RT1.D-u beta 20-44, or in vivo by oral administration of the peptide were tested for their ability to induce specific proliferation of LEW T cells primed in vivo to RT1.D-u beta 20-44. Results: In vitro pulsed intestinal epithelial cells induced specific proliferation of RT1.D-u beta 20-44-primed T cells. Intestinal epithelial cells isolated from LEW rats that received a single oral dose of RT1.D-u beta 20-44 18 hours earlier also induced specific proliferation of RT1.D-u beta 20-44-primed LEW T cells. Furthermore, epitheliaI cells harvested from LEW rats that received WF (RT1(u)) splenocytes orally 18 hours earlier induced specific proliferation of RT1.D-u beta 20-44-primed LEW T cells. Conclusions: Intestinal epithelial cells take up processed alloantigen in vitro and in vive for presentation as peptides to primed T cells. These observations provide a novel approach to study the role of the intestinal immune system in immune regulation in vivo.
引用
收藏
页码:1537 / 1542
页数:6
相关论文
共 36 条
  • [1] INDUCTION OF IA-ANTIGEN IN RAT EPIDERMAL-CELLS AND GUT EPITHELIUM BY IMMUNOLOGICAL STIMULI
    BARCLAY, AN
    MASON, DW
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1982, 156 (06) : 1665 - 1676
  • [2] BLAND PW, 1986, IMMUNOLOGY, V58, P9
  • [3] PASSAGE OF FERRITIN INTO JEJUNAL EPITHELIAL CELLS
    CASLEYSM.JR
    [J]. EXPERIENTIA, 1967, 23 (05): : 370 - +
  • [4] CERFBENSUSSAN N, 1984, J IMMUNOL, V132, P2244
  • [5] Colla G., 1972, ASTR ASTROPHYS S, V7, P1
  • [6] CORNELL R, 1971, LAB INVEST, V25, P42
  • [7] FUJIHASHI K, 1993, J IMMUNOL, V151, P6681
  • [8] HANCOCK WW, 1994, AM J PATHOL, V144, P1149
  • [9] ORAL, BUT NOT INTRAVENOUS, ALLOANTIGEN PREVENTS ACCELERATED ALLOGRAFT-REJECTION BY SELECTIVE INTRAGRAFT TH2 CELL ACTIVATION
    HANCOCK, WW
    SAYEGH, MH
    KWOK, CA
    WEINER, HL
    CARPENTER, CB
    [J]. TRANSPLANTATION, 1993, 55 (05) : 1112 - 1118
  • [10] HIGGINS PJ, 1988, J IMMUNOL, V140, P440